KRISTA HENSHAW: Open Payments
NPI 1568723419 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $782 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $242 |
| AstraZeneca Pharmaceuticals LP | 1 | $126 |
| Verona Pharma, Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| KYOWA KIRIN, INC. | 1 | $104 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $7 |
Products named: FASENRA, Ohtuvayre, Epclusa, VOQUEZNA, Ozempic, Wegovy, CRYSVITA, LifeVest.
Industry payments across DE — which companies pay providers there.
